triple agonist glp 1 Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care A peptide triple agonist of

Description

Egnatchik, R

American health & drug benefits

Strategic Implications If validated in prospective randomized trials, GLP-1 receptor agonists could: Represent an adjunctive strategy in obesity-associated asthma Expand the therapeutic footprint of GLP-1s beyond metabolic disease Influence treatment guidelines in high-BMI asthma populations Given the rapid adoption of GLP-1 therapies globally, further investigation into respiratory benefits could have significant clinical and commercial implications

Adding the Precision Peptide Genetic Test ($99 after your first month) personalizes your therapy by mapping 14 metabolic pathways and 49 peptides relevant to GLP-1 response, helping your provider optimize your protocol from month two onward